1. Beard DA, Schenkman KA, Feigl EO (2003) Myocardial oxygenation in isolated hearts predicted by an anatomically realistic microvascular transport model. Am J Physiol Heart Circ Physiol 285:H1826–H1836
2. Behnke N, Muller W, Neumann J, Schmitz W, Scholz H, Stein B (1990) Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-imine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cyclic AMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes. J Pharmacol Exp Ther 254:1017–1023
3. Belardinelli L, Linden J, Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73–97
4. Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807–813
5. Bruckner R, Fenner A, Meyer W, Nobis T-M, Schmitz W, Scholz H (1985) Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. J Pharmacol Exp Ther 234:766–774